"If you can have something by mouth that can quickly be taken and can, at least in the case of the Pfizer candidate, truly decrease hospitalization by 89% in someone who is high-risk, you are really defanging the virus," Dr. Nahid Bhadelia says.
"We are seeing innovative ways for how people are getting monoclonal antibodies to patients, including drive-up windows, drive-up service and treatment in people’s own homes," Dr. Preeti Malani says.
Today, On Point: Therapeutics and the part they’ll play in the fight against COVID-19.
Dr. James Crowe, professor at Vanderbilt University. Director of the Vanderbilt Vaccine Center (@VUMC_Vaccines) and Founder, Chief Scientist of the Global Pandemic Prevention and Biodefense Center AHEAD100 initiative.
Alice Carter, Boston-based professor of psychology, treated for COVID with monoclonal antibodies.
To download an unofficial .txt transcript of the interview, please click below.